Abegaz, Tadesse M.

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021

Brauer, M., Roth, G. A., Aravkin, A. Y., Zheng, P., Abate, K. H., Abate, Y. H., Abbafati, C., Abbasgholizadeh, R., Abbasi, M. A., Abbasian, M., et al. (2024) · The Lancet

Cardiovascular Health and Risk FactorsGlobal Public Health Policies and Epidemiology

Cited by 2,884

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

Schumacher, A. E., Kyu, H. H., Aali, A., Abbafati, C., Abbas, J., Abbasgholizadeh, R., Abbasi, M. A., Abbasian, M., Abd ElHafeez, S., Abdelmasseh, M., et al. (2024) · The Lancet

Insurance, Mortality, Demography, Risk ManagementCOVID-19 epidemiological studies

Cited by 1,045

Nonadherence to antihypertensive drugs: A systematic review and meta-analysis

Abegaz, T. M., Shehab, A., Gebreyohannes, E. A., Bhagavathula, A. S., & Elnour, A. A. (2017) · Medicine

Medication Adherence and ComplianceBlood Pressure and Hypertension Studies

Cited by 525

Glucagon-like Peptide-1 Receptor Agonists Associated Gastrointestinal Adverse Events: A Cross-Sectional Analysis of the National Institutes of Health All of Us Cohort

Aldhaleei, W. A., Abegaz, T. M., & Bhagavathula, A. S. (2024) · Pharmaceuticals

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 80

Rate of glycemic control and associated factors among type two diabetes mellitus patients in Ethiopia: a cross sectional study

Nigussie, S., Birhan, N., Amare, F., Mengistu, G., Adem, F., & Abegaz, T. M. (2021) · PLOS ONE

Diabetes Management and EducationDiabetes Management and Research

Cited by 62

Machine learning algorithms to predict major adverse cardiovascular events in patients with diabetes

Abegaz, T. M., Baljoon, A., Kilanko, O., Sherbeny, F., & Ali, A. A. (2023) · Computers in Biology and Medicine

Artificial Intelligence in HealthcareMachine Learning in Healthcare

Cited by 34

Cost effectiveness of dapagliflozin added to standard of care for the management of diabetic nephropathy in the USA

Abegaz, T. M., Diaby, V., Sherbeny, F., & Ali, A. A. (2022) · Clinical Drug Investigation

Health Systems, Economic Evaluations, Quality of LifeChronic Kidney Disease and Diabetes

Cited by 15